PHARMACOECONOMIC EVALUATION OF RUFINAMIDE USE FOR THE LENNOX-GASTAUT SYNDROME TREATMENT

• Main Authors: N. K. Mazina (Author), P. V. Mazin (Author), Yu. V. Kislitsin (Author), E. M. Markova (Author)
• Formato: Livro
• Publicado em: IRBIS LLC, 2016-04-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Among epileptic encephalopathies, the Lennox-Gastaut syndrome is considered to be one of the most severe. It is a childhood-onset disease that leads to early disability and mental retardation and is associated with significant costs of medical care and patient nursing. In the Russian Federation, the...